1 – 83 of 83
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Cancer risk in severe alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Cancer risk in severe alpha-1-antitrypsin deficiency: the importance of early identification
(
- Contribution to journal › Article
-
Mark
The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening
(
- Contribution to journal › Article
- 2021
-
Mark
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
(
- Contribution to journal › Article
- 2020
-
Mark
Decreased risk of ischemic heart disease in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison with the general population
(
- Contribution to journal › Article
-
Mark
Kardiellt troponin – en biomarkör för hjärt–kärlsjukdom vid KOL
(
- Contribution to journal › Article
- 2019
-
Mark
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years
(
- Contribution to journal › Article
-
Mark
Liver disease in adults with severe alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Oscillometry in Chronic Obstructive Lung Disease : In vitro and in vivo evaluation of the impulse oscillometry and tremoflo devices
(
- Contribution to journal › Article
-
Mark
Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD
(
- Contribution to journal › Article
- 2018
-
Mark
Deposition of inhaled nanoparticles is reduced in subjects with COPD and correlates with the extent of emphysema : Proof of concept for a novel diagnostic technique
(
- Contribution to journal › Article
-
Mark
Lung function and CT lung densitometry in 37-to 39-year-old individuals with alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
- 2017
-
Mark
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years
(
- Contribution to journal › Article
-
Mark
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency : an open-label extension trial (RAPID-OLE)
(
- Contribution to journal › Article
-
Mark
European Respiratory Society statement : Diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
(
- Contribution to journal › Article
-
Mark
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
(
- Contribution to journal › Article
- 2016
-
Mark
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
(
- Contribution to journal › Article
-
Mark
Vital capacity and COPD : The Swedish CArdioPulmonary bioImage Study (SCAPIS)
(
- Contribution to journal › Article
-
Mark
Recovery of inhaled nanoparticles, airflow obstruction and emphysema
2016) European Respiratory Society (ERS) Congress 2016(
- Contribution to conference › Abstract
- 2015
-
Mark
Chronic Obstructive Pulmonary Disease Is Common in Never-smoking Patients with Primary Sjögren Syndrome.
(
- Contribution to journal › Article
-
Mark
Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
(
- Contribution to journal › Article
-
Mark
The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Relationship between Change in Lung Density and Long-Term Progression of Lung Function.
(
- Contribution to journal › Letter
-
Mark
The Swedish Alpha 1-antitrypsin Screening Study: Health Status, Lung and Liver Function at Age 34.
2015) In Annals of the American Thoracic Society(
- Contribution to journal › Article
-
Mark
Using nanoparticles to detect emphysema
2015) European respiratory society international congress 2015(
- Contribution to conference › Abstract
-
Mark
Exhaled nanoparticles to detect emphysema
2015) The Fleischner Society annual meeting 2015(
- Contribution to conference › Abstract
- 2014
-
Mark
The forced oscillation technique is a sensitive method for detecting obstructive airway disease in patients with primary Sjögren's syndrome.
(
- Contribution to journal › Article
-
Mark
Survival benefit of lung transplantation for chronic obstructive pulmonary disease in sweden.
(
- Contribution to journal › Article
- 2012
-
Mark
Frequent development of chronic obstructive pulmonary disease in primary SS--results of a longitudinal follow-up.
(
- Contribution to journal › Article
-
Mark
Randomised controlled trial for emphysema with a selective agonist of the gamma-type retinoic acid receptor
(
- Contribution to journal › Article
- 2011
-
Mark
Eureka?
(
- Contribution to journal › Letter
-
Mark
Alpha-1-antitrypsin deficiency and periodontitis, a pilot study
(
- Contribution to journal › Article
-
Mark
The fibrinogen cleavage product A alpha-Val(360), a specific marker of neutrophil elastase activity in vivo
(
- Contribution to journal › Article
-
Mark
CT lung densitometry in young adults with alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Survival benefit of lung transplantation in individuals with severe α(1)-anti-trypsin deficiency (PiZZ) and emphysema.
(
- Contribution to journal › Article
-
Mark
Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ α1-antitrypsin deficiency.
(
- Contribution to journal › Article
- 2010
-
Mark
Plasma levels of TIMP-1 are higher in 34-year-old individuals with severe alpha 1-antitrypsin deficiency
(
- Contribution to journal › Letter
-
Mark
Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry
(
- Contribution to journal › Article
-
Mark
Survival in severe alpha-1-antitrypsin deficiency (PiZZ)
(
- Contribution to journal › Article
- 2009
-
Mark
Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha(1)-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Validity of apparent diffusion coefficient hyperpolarized He-3-MRI using MSCT and pulmonary function tests as references
(
- Contribution to journal › Article
-
Mark
Progression of Emphysema in a 12-month Hyperpolarized (3)He-MRI Study Lacunarity Analysis Provided a More Sensitive Measure than Standard ADC Analysis(1).
(
- Contribution to journal › Article
-
Mark
Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
(
- Contribution to journal › Article
-
Mark
The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Dark adaptation during systemic hypoxia induced by chronic respiratory insufficiency
(
- Contribution to journal › Article
- 2008
-
Mark
Assessment of Regional Progression of Pulmonary Emphysema With CT Densitometry
(
- Contribution to journal › Article
-
Mark
Endotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals
(
- Contribution to journal › Article
-
Mark
Hyperpolarized (3)He apparent diffusion coefficient MRI of the lung: Reproducibility and volume dependency in healthy volunteers and patients with emphysema.
(
- Contribution to journal › Article
-
Mark
Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ).
(
- Contribution to journal › Article
- 2007
-
Mark
Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development.
(
- Contribution to journal › Article
-
Mark
Progression parameters for emphysema: A clinical investigation
(
- Contribution to journal › Article
-
Mark
Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
(
- Contribution to journal › Article
- 2005
-
Mark
Variability in Densitometric Assessment of Pulmonary Emphysema With Computed Tomography.
(
- Contribution to journal › Article
-
Mark
{alpha}1-Antitrypsin Deficiency in 26-Year-Old Subjects: Lung, Liver, and Protease/Protease Inhibitor Studies.
(
- Contribution to journal › Article
- 2004
-
Mark
Comparison of the Sensitivities of 5 Different Computed Tomography Scanners for the Assessment of the Progression of Pulmonary Emphysema: A Phantom Study.
(
- Contribution to journal › Article
-
Mark
Increased plasma levels of serine proteinase inhibitors in lung cancer patients.
(
- Contribution to journal › Article
-
Mark
Analysis of systemic biomarkers in COPD patients.
(
- Contribution to journal › Article
- 2003
-
Mark
Experience with a new percutaneous port system, Percuseal(R), for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1-antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Circulating monocytes from healthy individuals and COPD patients.
(
- Contribution to journal › Article
-
Mark
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
(
- Contribution to journal › Article
- 2002
-
Mark
Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).
(
- Contribution to journal › Article
-
Mark
Nutritional status and muscle strength in patients with emphysema and severe alpha(1)-antitrypsin deficiency.
(
- Contribution to journal › Article
- 1999
-
Mark
Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ)
(
- Contribution to journal › Article
- 1998
-
Mark
Adolescents with alpha1-antitrypsin deficiency have high alpha2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma
(
- Contribution to journal › Article
-
Mark
Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ)
(
- Contribution to journal › Article
-
Mark
Lung function in alpha1-antitrypsin deficiency
1998)(
- Thesis › Doctoral thesis (compilation)
- 1997
-
Mark
Changes in aortic wall stiffness in men with alpha 1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ)
(
- Contribution to journal › Article
- 1995
-
Mark
Clinical features and lung function in 18-year-old adolescents with alpha 1-antitrypsin deficiency
(
- Contribution to journal › Article
- 1994
-
Mark
Efficacy and tolerance of a 12-week treatment with inhaled formoterol in patients with reversible obstructive lung disease
(
- Contribution to journal › Article
-
Mark
Lung function in adolescents with alpha 1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Alfa1-antitrypsinregistret behövs. Klinisk uppföljning av patienter underlättas
(
- Contribution to journal › Article
- 1993
-
Mark
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis
(
- Contribution to journal › Article
- 1990
-
Mark
Nationell samordning nödvändig för ökad kunskap om alfa1-antitrypsinbrist
(
- Contribution to journal › Article
-
Mark
Inflammatory indices for chronic bronchitis and chronic obstructive airway disease. Cell populations in bronchial and bronchoalveolar lavage
(
- Contribution to journal › Article
- 1988
-
Mark
Non-tuberculous mycobacterial infection--a major cause of tuberculin conversion in unvaccinated children in south Sweden
(
- Contribution to journal › Article